Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Ureteroscopy-assisted retrograde nephrostomy for a large and obstructive renal pelvic stone: a case report

  • Takashi Kawahara1, 2Email author,
  • Hiroki Ito1, 2,
  • Hideyuki Terao1,
  • Hiroji Uemura2,
  • Yoshinobu Kubota2 and
  • Junichi Matsuzaki1
Journal of Medical Case Reports20159:44

https://doi.org/10.1186/s13256-015-0529-4

Received: 5 August 2014

Accepted: 14 January 2015

Published: 27 February 2015

Abstract

Introduction

We have previously described the use of ureteroscopy-assisted retrograde nephrostomy. However, reaching the target calyx with the ureteroscope is difficult in patients with obstructive renal pelvic stones.

Case presentation

A 53-year-old Japanese woman was referred to our department for the treatment of a right renal stone. She was admitted to our department for percutaneous nephrolithotomy of a right renal stone located at her ureteropelvic junction. A Lawson retrograde nephrostomy puncture wire was subsequently inserted into the flexible ureteroscope, and we successfully punctured the calyx from the target spot to the skin. The nephrostomy was dilated, and the stone fragments were obtained and removed.

Conclusions

We here report the case of a large and obstructive renal stone successfully treated with percutaneous nephrolithotomy using the ureteroscopy-assisted retrograde nephrostomy technique.

Keywords

PCNLUARNUreteroscopy

Introduction

Goodwin et al. first reported obtaining percutaneous renal access in 1955 [1]. Subsequently, the technique of percutaneous nephrolithotomy (PCNL) was developed and has since become the standard procedure for treating large renal stones [2]. In the ureteroscopy-assisted retrograde nephrostomy (UARN) technique, it is possible to continuously visualize the area of dilation from the time of puncture to insertion of the nephron access sheath (NAS). In patients with obstructive renal pelvic stones, reaching the target calyx with a ureteroscope (URS) is difficult. In most cases, it is feasible to reach the target calyx next to large renal calculi. However, in some cases, it is not possible to reach the target calyx due to the presence of a renal stone occupying the area of the ureteropelvic junction. We here report a case of a large and obstructive renal stone successfully treated with PCNL using UARN.

Case presentation

A 53-year-old Japanese woman was referred to our department for the treatment of a right, large, obstructive renal pelvic stone and smaller lower pole calyceal stone (Figures 1a and 1b). She had no remarkable previous or family history, and the laboratory data showed no remarkable findings, except for microhematuria on a urine analysis. In April 2011, she was admitted to our department for PCNL to treat a right renal stone located at her ureteropelvic junction. In brief, under general and epidural anesthesia, she was placed in a modified-Valdivia position (Galdakao-modified Valdivia position) [3]. A flexible URS (Flex-X2, Karl Storz, Germany) was inserted through an inserted ureteral access sheath (Flexor® 12-Fr, 35cm, Cook Urological, USA) into her ureter. A stone occupied the area around her ureteropelvic junction, and the URS could not be advanced to the target calyx. Therefore, we first made a root using holmium:yttrium-aluminum-garnet (Ho:YAG) laser lithotripsy in order to reach the target calyx. Intracorporeal lithotripsy was subsequently performed using a Ho:YAG laser (with a 200μm fiber, 1.0J, 5Hz; VersaPulse® 30W, Lumenis Surgical, USA), and the URS was then advanced to the target spot in order to puncture it through the root.
Figure 1

Pre- and post- operative images. (a) Preoperative kidney, ureter and bladder and (b) axial computed tomography. (c) Postoperative kidney, ureter and bladder.

Next, a Lawson retrograde nephrostomy puncture wire (Cook Urological) was inserted into the flexible URS, and the calyx was successfully punctured from the target spot to the skin. A 24-Fr percutaneous NAS (X-Force® nephrostomy balloon dilation catheter, BARD Medical, USA) was passed over the balloon under continuous visualization with the URS, and, following insertion of the NAS into the renal collecting system, calculus fragmentation was undertaken using a Swiss LithoClast® pneumatic lithotripter (EMS, Switzerland) through a rigid nephroscope (percutaneous nephroscope, Karl Storz, Germany). A postoperative kidney, ureter and bladder film showed no residual stones (Figure 1c). The length of the operation was 175 minutes; no major or minor complications were observed. The postoperative ureteral stent was removed 2 weeks after the procedure, and no residual stone fragments or signs of postoperative ureteral stricture were noted on computed tomography . A stone analysis showed the stone to be composed of calcium oxalate.

Conclusions

We previously reported the application of UARN and confirmed its effectiveness during PCNL [3]. With the UARN technique, the nephrostomy can be made easily at the target puncture site under continuous visualization. The present procedure for performing UARN during PCNL has several advantages. For example, after the needle exits through the skin, no further steps are required in preparation for dilation [3-5].

In recent years, major advances have made observation of the renal pelvis easier, making it possible to perform a wide variety of intrarenal procedures using a URS [3]. Therefore, it is now easier to approach the desired renal calyx using a flexible URS than was previously possible using the fluoroscopic approach [4,6]. In our experience with UARN, the URS can be applied to continuously obtain the ideal angle.

As observed in the current case, the URS sometimes is unable to reach the renal collecting system due to the presence of a large stone at the ureteropelvic junction. Making the nephrostomy in cases of hydronephrosis is easy; however, puncturing the target calyx is important in order to free the stone in cases similar to the present case.

We here reported a case of a large and obstructive renal stone successfully treated with PCNL using UARN.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent form is available for review by the Editor-in-Chief of this journal.

Abbreviations

Ho:YAG: 

Holmium:yttrium-aluminum-garnet

NAS: 

Nephron access sheath

PCNL: 

Percutaneous nephrolithotomy

UARN: 

Ureteroscopy-assisted retrograde nephrostomy

URS: 

Ureteroscopy

NAS: 

Nephro access sheath

Declarations

Authors’ Affiliations

(1)
Department of Urology, Ohguchi Higashi General Hospital
(2)
Department of Urology, Yokohama City University Graduate School of Medicine

References

  1. Goodwin WE, Casey WC, Woolf W. Percutaneous trocar (needle) nephrostomy in hydronephrosis. J Am Med Assoc. 1955;157(11):891–4.View ArticlePubMedGoogle Scholar
  2. Obek C, Onal B, Kantay K, Kalkan M, Yalcin V, Oner A, et al. The efficacy of extracorporeal shock wave lithotripsy for isolated lower pole calculi compared with isolated middle and upper caliceal calculi. J Urol. 2001;166(6):2081–4. discussion 2085.View ArticlePubMedGoogle Scholar
  3. Kawahara T, Ito H, Terao H, Yoshida M, Ogawa T, Uemura H, et al. Ureteroscopy assisted retrograde nephrostomy: a new technique for percutaneous nephrolithotomy (PCNL). BJU Int. 2012;110(4):588–90.View ArticlePubMedGoogle Scholar
  4. Hunter PT, Finlayson B, Drylie DM, Leal J, Hawkins IF. Retrograde nephrostomy and percutaneous calculus removal in 30 patients. J Urol. 1985;133(3):369–74.PubMedGoogle Scholar
  5. Hawkins Jr IF, Hunter P, Leal G, Nanni G, Hawkins M, Finlayson B, et al. Retrograde nephrostomy for stone removal: combined cystoscopic/percutaneous technique. AJR Am J Roentgenol. 1984;143(2):299–304.View ArticlePubMedGoogle Scholar
  6. Lawson RK, Murphy JB, Taylor AJ, Jacobs SC. Retrograde method for percutaneous access to kidney. Urology. 1983;22(6):580–2.View ArticlePubMedGoogle Scholar

Copyright

© Kawahara et al.; licensee BioMed Central. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement